Literature DB >> 6035527

Oestrogen conjugates of human late-pregnancy urine.

E R Smith, A E Kellie.   

Abstract

1. The separation of the oestrogen conjugates in late-pregnancy urine into two groups, peaks I and II, by gel filtration on Sephadex G-25 (Beling, 1963) has been shown to be affected by the presence of urate, which delays the elution of peak II conjugates. 2. By reapplication to a Sephadex column, peak I conjugates have been further separated into two groups (peaks IA and IB) and the metabolites in urine effecting this separation have been studied. 3. Further analysis of the mixed conjugates in the main groups IA, IB and II by ion-exchange and partition chromatography has led to the identification of some of the conjugates present. 4. Oestriol 3-sulphate 16alpha-glucuronide and 16alpha-hydroxyoestrone 3-sulphate 16alpha-glucuronide have been identified in peak IA. 5. The main components of peak IB have been identified as oestrone 3-glucuronide and oestriol 3-glucuronide. 6. The major conjugate in peak II was oestriol 16alpha-glucuronide and no oestriol 17beta-glucuronide was found; small amounts of the ring-d monoglucuronides oestradiol 17beta-glucuronide, 16-epioestriol 16beta-glucuronide and 16alpha-hydroxyoestrone 16alpha-glucuronide were found in this fraction. 7. The behaviour of synthetic oestrogen monoglucuronides has been used as a guide in separation.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6035527      PMCID: PMC1270548          DOI: 10.1042/bj1040083

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  18 in total

1.  OESTRIOL METABOLISM IN AN ANENCEPHALIC MONSTER.

Authors:  E DICZFALUSY; M BARR; J LIND
Journal:  Acta Endocrinol (Copenh)       Date:  1964-08

2.  OESTRIOL METABOLISM IN PREGNANT WOMEN.

Authors:  R WILSON; G ERIKSSON; E DICZFALUSY
Journal:  Acta Endocrinol (Copenh)       Date:  1964-08

3.  Isolation and characterization of estriol 16 alpha-glucosiduronic acid from human pregnancy urine

Authors:  Y HASHIMOTO; M NEEMAN
Journal:  J Biol Chem       Date:  1963-04       Impact factor: 5.157

4.  BLOOD ESTRIOL CONJUGATION DURING HUMAN PREGNANCY.

Authors:  J C TOUCHSTONE; J W GREENE; R C MCELROY; T MURAWEC
Journal:  Biochemistry       Date:  1963 Jul-Aug       Impact factor: 3.162

5.  Studies on sulphatases. 4. Arylsulphatase and beta-glucuronidase concentrates from limpets.

Authors:  K S DODGSON; B SPENCER
Journal:  Biochem J       Date:  1953-09       Impact factor: 3.857

6.  Oestriolglycuronide.

Authors:  S L Cohen; G F Marrian; A D Odell
Journal:  Biochem J       Date:  1936-12       Impact factor: 3.857

7.  The biosynthesis of labeled estriol-3-sulfate-16-glucosiduronate.

Authors:  M Levitz; J Katz; G H Twombly
Journal:  Steroids       Date:  1965-11       Impact factor: 2.668

8.  The synthesis of oestrogen monoglucuronides.

Authors:  J S Elce; J G Carpenter; A E Kellie
Journal:  J Chem Soc Perkin 1       Date:  1967

9.  Oestriol-3-glucosiduronate, a major urinary metabolite of oestriol and oestriol-16(17?)-glucosiduronate.

Authors:  U Goebelsmann; K Sjöberg; N Wiqvist; E Diczfalusy
Journal:  Acta Endocrinol (Copenh)       Date:  1965-10

10.  A study of the colorimetric estimation of oestradiol-17 beta, oestradiol-17 alpha, oestrone, oestriol and 16-epioestriol by the Kober reaction.

Authors:  W NOCKE
Journal:  Biochem J       Date:  1961-03       Impact factor: 3.857

View more
  3 in total

1.  Determination of oestrogen monoglucuronides by the Brown method.

Authors:  H A Blair; A E Kellie
Journal:  Biochem J       Date:  1968-05       Impact factor: 3.857

2.  Studies on phenolic steroids in human subjects. 8. Metabolism of estriol-16 alpha-glucosiduronate.

Authors:  N Inoue; A A Sandberg; J B Graham; W R Slaunwhite
Journal:  J Clin Invest       Date:  1969-02       Impact factor: 14.808

3.  Studies on phenolic steroids in human subjects. IX. Role of the intestine in the conjugation of estriol.

Authors:  N Inoue; A A Sandberg; J B Graham; W R Slaunwhite
Journal:  J Clin Invest       Date:  1969-02       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.